“The inhibitory activity of rapid, reversible COX inhibitors (ibuprofen, naproxen, mefenamic acid , and lumiracoxib) demonstrated a significant increase in potency and time dependence of inhibition against double tryptophan murine COX-2 mutants at the 89/90 and 89/119 positions.”